DCP
ABBV icon

DSM Capital Partners’s AbbVie ABBV Stock Holding History

DSM Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,630
Closed -$856K – 42
2015
Q1 		$856K Sell
14,630
-79,575
-84% -$4.81M 0.01% 37
2014
Q4 		$6.17M Sell
94,205
-25,275
-21% -$1.59M 0.11% 35
2014
Q3 		$6.9M Buy
+119,480
New +$6.63M 0.14% 36

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

DSM Capital Partners's ABBV Position: Q2 2015 in Review

DSM Capital Partners sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 14,630 shares — an estimated $856K sold.

DSM Capital Partners first reported a position in ABBV in Q3 2014 and held it in 3 quarters. The position peaked at $6.9M in Q3 2014. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

  • DSM Capital Partners reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
  • DSM Capital Partners sold 14,630 AbbVie shares in Q2 2015, an estimated $856K.
  • DSM Capital Partners first reported a position in AbbVie in Q3 2014 and held it in 3 quarters.
  • DSM Capital Partners's AbbVie position peaked at $6.9M in Q3 2014.
  • 1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on DSM Capital Partners's 13F filing for Q2 2015, filed 13 Aug 2015.